Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Comp Immunol Microbiol Infect Dis ; 74: 101578, 2021 Feb.
Article En | MEDLINE | ID: mdl-33246241

Since its emergence in Nigeria, canine parvovirus type 2 (CPV-2) infection has posed problems to dog breeding and requires constant awareness and monitoring. In this study, the status, the assessment of extrinsic risk factors of parvoviral infection in dog kennels in North Central Nigeria, and isolation of the CPV-2 were carried out. Potential risk factors were considered during sampling: age, breed, sex, location, vaccination and health status, using well-structured questionnaires on dog owners with experience of CPV-2 infection. There was high prevalence which depended on age, breed, location, clinical status of the dog while vaccination status of the dogs did not influence the prevalence. CPV-2 vaccination compliance by the breeders and management system of the kennels were also observed as risk factors. Isolation of CPV-2a and -2c strains from Nigeria for further study has been reported. The spread of CPV-2 in Nigeria is increasing, hence needs for continual epidemiological monitoring and review.


Dog Diseases , Parvoviridae Infections , Parvovirus, Canine , Animals , Dog Diseases/epidemiology , Dogs , Nigeria/epidemiology , Parvoviridae Infections/epidemiology , Parvoviridae Infections/veterinary , Parvovirus, Canine/genetics , Phylogeny , Risk Factors
2.
Transbound Emerg Dis ; 67(2): 635-647, 2020 Mar.
Article En | MEDLINE | ID: mdl-31580520

Canine parvovirus type 2 (CPV-2) emerged suddenly in the late 1970s as pathogen of dogs, causing a severe and often fatal gastroenteric disease. The original CPV-2 was replaced by three antigenic variants, CPV-2a, CPV-2b and CPV-2c, which to date have gained a worldwide distribution with different relative proportions. All previous studies conducted in Africa were based on partial VP2 gene sequences. The aim of this study was to provide a genome analysis to characterize the CPV strains collected in Nigeria, Africa. Rectal swab samples (n = 320) were collected in 2018 and tested by means of an immunochromatographic assay. Among the 144 positive samples, 59 were selected for further analyses using different molecular assays. The results revealed a high prevalence of CPV-2c (91.5%) compared to the CPV-2a variant (8.5%). The VP2 gene sequences showed a divergence from the strains analysed in 2010 in Nigeria and a closer connection with CPV strains of Asian origin. The non-structural gene analysis evidenced amino acid changes never previously reported. The molecular analysis based on genomic sequences evidenced a geographical pattern of distribution of the analysed strains, suggesting a potential common evolutionary origin with CPV of Asian origin. This study represents the first CPV molecular characterization including all the encoding gene sequences conducted in the African continent and contributes to define the current geographical spread of the CPV variants worldwide.


Dog Diseases/virology , Genome, Viral/genetics , Parvoviridae Infections/veterinary , Parvovirus, Canine/genetics , Animals , Dog Diseases/epidemiology , Dogs , Nigeria/epidemiology , Parvoviridae Infections/epidemiology , Parvoviridae Infections/virology , Parvovirus, Canine/isolation & purification , Phylogeny , Prevalence
3.
Parasit Vectors ; 12(1): 420, 2019 Aug 27.
Article En | MEDLINE | ID: mdl-31455430

BACKGROUND: Animal trypanosomosis is endemic in Nigeria, while the human disease caused by Trypanosoma brucei gambiense is rarely reported nowadays after efforts to bring it under control in the 20th century. The University of Nigeria Veterinary Teaching Hospital (UNVTH) is a reference centre located within the Nsukka area and serves Enugu and neighboring states, Benue, Kogi, Anambra and Delta. Among dogs presented to the UNVTH with canine trypanosomosis, T. brucei is frequently reported as the causative agent. However, this is by morphological identification under the microscope, which does not allow distinction of human-infective (T. b. gambiense) and non-human-infective (T. b. brucei) subspecies. Here, we used subspecies-specific PCR tests to distinguish T. b. gambiense and T. b. brucei. METHODS: Blood samples were collected on FTA cards from 19 dogs presenting with clinical signs of trypanosomosis at the UNVTH from January 2017 to December 2018. All dogs had a patent parasitaemia. DNA was extracted from the FTA cards using Chelex 100 resin and used as template for PCR. RESULTS: All infections were initially identified as belonging to subgenus Trypanozoon using a generic PCR test based on the internal transcribed spacer 1 (ITS1) of the ribosomal RNA locus and a PCR test specific for the 177 bp satellite DNA of subgenus Trypanozoon. None of the samples were positive using a specific PCR test for T. evansi Type A kinetoplast DNA minicircles. Further PCR tests specific for T. b. gambiense based on the TgsGP and AnTat 11.17 genes revealed that two of the dogs harboured T. b. gambiense. In addition to trypanosomes of subgenus Trypanozoon, T. congolense savannah was identified in one dog using a species-specific PCR test for this taxon. CONCLUSIONS: Nineteen dogs presenting with canine African trypanosomosis at UNVTH were infected with trypanosomes of the T. brucei group and in two cases the trypanosomes were further identified to subspecies T. b. gambiense using specific PCR tests. Thus T. b. gambiense is one of the parasites responsible for canine African trypanosomosis in the Nsukka area of Nigeria and represents a serious danger to human health.


Dog Diseases/epidemiology , Dog Diseases/parasitology , Trypanosomiasis, African/veterinary , Animals , DNA, Protozoan/genetics , DNA, Ribosomal Spacer/genetics , Dog Diseases/diagnosis , Dogs , Female , Male , Nigeria/epidemiology , Trypanosoma brucei gambiense/genetics , Trypanosoma brucei gambiense/isolation & purification , Trypanosomiasis, African/epidemiology
...